Atlas Trials

Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD)

Clinical trial NCT07721922 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07721922
Sponsor
University of Tennessee Graduate School of Medicine
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
COPD Exacerbation
Start date
2026-09-01
Primary completion
2028-09-01
Enrollment
280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.